Anna Marie Wagner

Overview

Anna Marie Wagner is a seasoned executive and angel investor specializing in early-stage biotechnology and technology companies in the United States. She currently serves as the Senior Vice President of Corporate Development at Ginkgo Bioworks, a leading synthetic biology company based in Boston, Massachusetts. In this role, she has been instrumental in driving strategic partnerships and corporate growth initiatives. Prior to her tenure at Ginkgo Bioworks, Anna Marie held various leadership positions, including serving as the Interim Chief Financial Officer and leading the company's public offering in 2021, which raised $1.6 billion—the largest-ever go-public raise in biotech at that time. Her extensive experience spans both investing and operating roles in hypergrowth and mature companies, with a particular focus on technology and life sciences sectors. In addition to her corporate responsibilities, Anna Marie is actively involved in the investment community as an angel investor. She has a track record of supporting early-stage companies, notably investing in JobGet during its seed round in October 2020. Her investment philosophy centers on leveraging her deep industry knowledge to identify and nurture innovative startups poised for significant impact. Anna Marie holds a Bachelor of Arts in Applied Mathematics and Economics from Harvard University and an MBA from Harvard Business School, where she was recognized as a Baker Scholar. She also serves as an Executive Fellow at Harvard Business School, co-teaching an elective course on failure, reflecting her commitment to education and mentorship in the entrepreneurial ecosystem.

Investment Focus

• Innovative business models
• Scalable growth potential
• Strong management teams

Portfolio Companies